Home
PCI Synthesis

PCI Synthesis Market Share Analysis for January 2026

we are full-service cgmp active pharmaceutical ingredients (api) contract manufacturing company of nce & drug products

Health > Biotechnology and Pharmaceuticals

Domainpcisynthesis.com

Year Founded1996

Employees51 - 200

Annual Revenue$25M - $50M

PCI Synthesis

PCI Synthesis (including company regionals)

pcisynthesis.com

See more website traffic and engagement information

PCI Synthesis Revenue up to January 2026 is 25M - 50M

revenue generated by PCI Synthesis top domains

PCI Synthesis top domains revenue over 3 years

Revenue for PCI Synthesis top domains

pcisynthesis.com25M - 50M

See more with Sales Intelligence

Total visits to PCI Synthesis's top domains

Understand PCI Synthesis market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in PCI Synthesis's top domains

Analyze PCI Synthesis engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on PCI Synthesis's top domains

See how PCI Synthesis keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

PCI Synthesis top competitors by domain

Top similar sites in January 2026, ranked by their affinity

advancedsynthesis.comCompany NameAdvanced SynthesisEmployees51 - 200HQUnited States, California, San YsidroAnnual revenue$15M - $25MTotal visits560Health > Biotechnology and Pharmaceuticals

Top technologies used by PCI Synthesis

These are the website technologies, by industry, used by PCI Synthesis top domains

Content Management System (3)

WordPress

Widget (3)

reCAPTCHA

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

More Technologies

6

See all

News & Signals from PCI Synthesis

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsPcisynthesis hired Bob Huang as Managing Director for North America on Sep 14th '21.Seqens CDMO North America (formerly known as PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs) and other specialty chemical products, today announced that Bob Huang has joined as Managing Director for North America.

NewsPcisynthesis hired Jean-Noel David as Managing Director for North America on Sep 15th '20.Newburyport, MA & Ecully, FRANCE, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Seqens CDMO North America (formerly known as PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that it has appointed Jean-Noel David as Managing Director for North America.

NewsPcisynthesis receives award awards in each of the six major award categories.Although PolyCarbon Industries, Inc. won awards in each of the six major award categories, and in addition received six other awards in specialty categories, PolyCarbon Industries, Inc. consider Reliability to be the among the most vital to sponsors.